AI assistant
IRADIMED CORP — Director's Dealing 2021
Aug 12, 2021
32324_dirs_2021-08-11_843061d5-0cae-4519-9a7b-6e49f20e25e8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2021-08-09
Reporting Person: HAWKINS JAMES B (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-09 | Common Stock | A | 4609 | $1.2857 | Acquired | 21877 | Direct |
| 2021-08-09 | Common Stock | S | 4609 | $35.8267 | Disposed | 17268 | Direct |
| 2021-08-10 | Common Stock | A | 5000 | $1.2857 | Acquired | 22268 | Direct |
| 2021-08-10 | Common Stock | S | 5000 | $35.7239 | Disposed | 17268 | Direct |
| 2021-08-11 | Common Stock | A | 7891 | $1.2857 | Acquired | 25159 | Direct |
| 2021-08-11 | Common Stock | S | 7891 | $35.1952 | Disposed | 17268 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-09 | Stock Options (Right to Buy) | $1.2875 | M | 4609 | Disposed | 2022-11-20 | Common Stock (4609) | Direct |
| 2021-08-10 | Stock Options (Right to Buy) | $1.2875 | M | 5000 | Disposed | 2022-11-20 | Common Stock (5000) | Direct |
| 2021-08-11 | Stock Options (Right to Buy) | $1.2875 | M | 7891 | Disposed | 2022-11-20 | Common Stock (7891) | Direct |
Footnotes
F1: This option, representing a right to purchase a total of 17,500 shares, was granted on 11/20/2012 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.
F2: This transaction was executed in multiple trades at prices ranging from $35.50 to 36.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $35.30 to 36.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4: This transaction was executed in multiple trades at prices ranging from $34.85 to 35.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.